Can Nimesulide Nanoparticles Be a Therapeutic Strategy for the Inhibition of the KRAS/PTEN Signaling Pathway in Pancreatic Cancer?

Pancreatic cancer is an aggressive, devastating disease due to its invasiveness, rapid progression, and resistance to surgical, pharmacological, chemotherapy, and radiotherapy treatments. The disease develops from PanINs lesions that progress through different stages. KRAS mutations are frequently o...

Descripción completa

Detalles Bibliográficos
Autores principales: Ferreira, Roseane Guimarães, Narvaez, Luis Eduardo Mosquera, Espíndola, Kaio Murilo Monteiro, Rosario, Amanda Caroline R. S., Lima, Wenddy Graziela N., Monteiro, Marta Chagas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8329661/
https://www.ncbi.nlm.nih.gov/pubmed/34354940
http://dx.doi.org/10.3389/fonc.2021.594917

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8329661/
https://www.ncbi.nlm.nih.gov/pubmed/34354940
http://dx.doi.org/10.3389/fonc.2021.594917

Ejemplares similares